YULEIDY ANDARCIO LUJAN: Open Payments
NPI 1447892179 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,239 in 56 payments from 6 companies in 2025. Trend: 2023 $22 · 2024 $431 · 2025 $1,239
Food & beverage: $1,239
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 28 | $563 |
| ABBVIE INC. | 8 | $203 |
| GENZYME CORPORATION | 5 | $179 |
| Paratek Pharmaceuticals, Inc. | 10 | $171 |
| Incyte Corporation | 3 | $74 |
| Novartis Pharmaceuticals Corporation | 2 | $49 |
Products named: Bimzelx, DUPIXENT, SKYRIZI, NUZYRA, OPZELURA, COSENTYX, RINVOQ.
Industry payments across FL — which companies pay providers there.
